Not logged in Share Save
Share Save
Gastric Cancer, Version 2.2025 Ajani, Jaffer A.; D'Amico, Thomas A.; Bentrem, David J.; Corvera, Carlos U.; Das, Prajnan; Enzinger, Peter C.; Enzler, Thomas; Gerdes, Hans; Gibson, Michael K.; Grierson, Patrick; Gupta, Garima; Hofstetter, Wayne L.; Ilson, David H.; Jalal, Shadia; Kim, Sunnie; Kleinberg, Lawrence R.; Klempner, Samuel; Lacy, Jill; Lee, Byrne; Licciardi, Frank; Lloyd, Shane; Ly, Quan P.; Matsukuma, Karen; McNamara, Michael; Merkow, Ryan P.; Miller, Aaron M.; Mukherjee, Sarbajit; Mulcahy, Mary F.; Perry, Kyle A.; Pimiento, Jose M.; Reddi, Deepti M.; Reznik, Scott; Roses, Robert E.; Strong, Vivian E.; Su, Stacey; Uboha, Nataliya; Wainberg, Zev A.; Willett, Christopher G.; Woo, Yanghee; Yoon, Harry H.; McMillian, Nicole R.; Stein, MaryElizabeth Share Save
Share Save
Share Save
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma Shitara, Kohei; Shah, Manish A.; Lordick, Florian; Van Cutsem, Eric; Ilson, David H.; Klempner, Samuel J.; Kang, Yoon-Koo; Lonardi, Sara; Hung, Yi-Ping; Yamaguchi, Kensei; Enzinger, Peter; Nakajima, Tomoko; Matsangou, Maria; Cao, Ying; Li, Ran; Moran, Diarmuid; Pophale, Rupesh; Oh, Mok; Ranganath, Radhika; Ajani, Jaffer A.; Xu, Rui-Hua Share Save
First-line (1L) zolbetuximab plus chemotherapy in patients (pts) with claudin 18.2 (CLDN18.2) +, HER2-, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: A pooled final analysis of SPOTLIGHT plus GLOW Kang, Y-K.; Shah, M. A.; Shitara, K.; Ajani, J. A.; Lordick, F.; Van Cutsem, E.; Ilson, D. H.; Klempner, S. J.; Yamaguchi, K.; Nakajima, T.; Cao, Y. J.; Li, R.; Moran, D.; Pophale, R. R.; Ranganath, R.; Xu, R-H. Share Save
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery Kachnic, Lisa A.; Winter, Kathryn; Suntharalingam, Mohan; Ilson, David; Konski, Andre; Lloyd, Shane; Mcavoy, Sarah A.; Lad, Thomas; Olowokure, Olugbenga Gbenga; Samson, Pamela; Gore, Elizabeth M.; Meyer, Joshua E.; Videtic, Gregory M. M.; Clump, David A.; Raben, Adam; Kayaleh, Omar; Barker Jr, Jerry; Haddock, Michael G.; Hopkins, Judith O.; Bruner, Deborah W. Share Save
Share Save
Share Save
Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab plus CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma Lordick, F.; Shah, M. A.; Shitara, K.; Ajani, J. A.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; van Cutsem, E.; Gallego Plazas, J.; Huang, J.; Shen, L.; Oh, S. C.; Sunpaweravong, P.; Soo, H. H. F.; Turk, H. M.; Park, J. W.; Moran, D.; Bhattacharya, P.; Cao, Y. J.; Xu, R-H. Share Save
Updated efficacy and safety results from phase III SPOTLIGHT study evaluating zolbetuximab+mFOLFOX6 as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma Ajani, J. A.; Lordick, F.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; Shah, M. A.; van Cutsem, E.; Xu, R-H.; Aprile, G.; Xu, J.; Pazo Cid, R. A.; Kang, Y-K.; Yang, J.; Moran, D.; Bhattacharya, P.; Matsangou, M.; Arozullah, A.; Park, J. W.; Shitara, K. Share Save
Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade Harrold, Emily C.; Foote, Michael B.; Rousseau, Benoit; Walch, Henry; Kemel, Yelena; Richards, Allison L.; Keane, Fergus; Cercek, Andrea; Yaeger, Rona; Rathkopf, Dana; Segal, Neil H.; Patel, Zalak; Maio, Anna; Borio, Matilde; O'Reilly, Eileen M.; Reidy, Diane; Desai, Avni; Janjigian, Yelena Y.; Murciano-Goroff, Yonina R.; Carlo, Maria I.; Latham, Alicia; Liu, Ying L.; Walsh, Michael F.; Ilson, David; Rosenberg, Jonathan E.; Markowitz, Arnold J.; Weiser, Martin R.; Rossi, Anthony M.; Vanderbilt, Chad; Mandelker, Diana; Bandlamudi, Chaitanya; Offit, Kenneth; Berger, Michael F.; Solit, David B.; Saltz, Leonard; Shia, Jinru; Diaz, Luis A., Jr.; Stadler, Zsofia K. Share Save
Updated efficacy and safety results from phase III SPOTLIGHT study evaluating zolbetuximab+mFOLFOX6 as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma Ajani, J. A.; Lordick, F.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; Shah, M. A.; Van Cutsem, E.; Xu, R-H.; Aprile, G.; Xu, J.; Cid, R. A. Pazo; Kang, Y-K.; Yang, J.; Moran, D.; Bhattacharya, P.; Matsangou, M.; Arozullah, A.; Park, J. W.; Shitara, K. Share Save
Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab plus CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma Lordick, F.; Shah, M. A.; Shitara, K.; Ajani, J. A.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; Van Cutsem, E.; Plazas, J. Gallego; Huang, J.; Shen, L.; Oh, S. C.; Sunpaweravong, P.; Soo, H. H. F.; Turk, H. M.; Park, J. W.; Moran, D.; Bhattacharya, P.; Cao, Y. J.; Xu, R-H. Share Save
Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer Lumish, Melissa A.; Walch, Henry; Maron, Steven B.; Chatila, Walid; Kemel, Yelena; Maio, Anna; Ku, Geoffrey Y.; Ilson, David H.; Won, Elizabeth; Li, Jia; Joshi, Smita S.; Gu, Ping; Schattner, Mark A.; Laszkowska, Monika; Gerdes, Hans; Jones, David R.; Sihag, Smita; Coit, Daniel G.; Tang, Laura H.; Strong, Vivian E.; Molena, Daniela; Stadler, Zsofia K.; Schultz, Nikolaus; Janjigian, Yelena Y.; Cercek, Andrea Share Save
Prognostic value of circumferential radial margin involvement in esophagectomy for esophageal cancer: a case series Boerner, Thomas; Carr, Rebecca; Hsu, Meier; Tan, Kay See; Sigel, Carlie; Tang, Laura; Harrington, Caitlin; Ku, Geoffrey Y.; Ilson, David H.; Janjigian, Yelena Y.; Wu, Abraham J.; Sihag, Smita; Bains, Manjit S.; Bott, Matthew J.; Isbell, James M.; Park, Bernard J.; Jones, David R.; Molena, Daniela Share Save
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial Shah, Manish A.; Shitara, Kohei; Ajani, Jaffer A.; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Lordick, Florian; Van Cutsem, Eric; Plazas, Javier Gallego; Huang, Jing; Shen, Lin; Oh, Sang Cheul; Sunpaweravong, Patrapim; Soo Hoo, Hwoei Fen; Turk, Haci Mehmet; Oh, Mok; Park, Jung Wook; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Xu, Rui-Hua Share Save
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro- oesophageal junction adenocarcinoma (SPOTLIGHT) : a multicentre, randomised, double-blind, phase 3 trial Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Shah, Manish A.; Van Cutsem, Eric; Xu, Rui-Hua; Aprile, Giuseppe; Xu, Jianming; Chao, Joseph; Pazo-Cid, Roberto; Kang, Yoon-Koo; Yang, Jianning; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Park, Jung Wook; Oh, Mok; Ajani, Jaffer A. Share Save
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma A Phase Ib/II Study Cowzer, Darren; Wu, Abraham Jing-Ching; Sihag, Smita; Walch, Henry S.; Park, Bernard J.; Jones, David R.; Gu, Ping; Maron, Steven B.; Sugarman, Ryan; Chalasani, Sree Bhavani; Shcherba, Marina; Capanu, Marinela; Chou, Joanne F.; Choe, Jennie K.; Nosov, Anton; Adusumilli, Prasad S.; Yeh, Randy; Tang, Laura H.; Ilson, David H.; Janjigian, Yelena Y.; Molena, Daniela; Ku, Geoffrey Y. Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
.png)
ANNALS OF ONCOLOGY.png)
